DSP Ultra Short Fund An open ended ultra-short term debt scheme investing in debt and money market securities such that the Macaulay duration of the portfolio is between 3 months and 6 months (please refer page no. 21 under the section “Where will the Scheme invest?” in the SID for details on Macaulay’s Duration) |
Enhanced cash fund
Suitable for investing surplus cash over short-term, alternative to on-demand deposits
Kedar Karnik
Total work experience of 13 years.
Managing this Scheme since
July 2016.
Rahul Vekaria
Total work experience of 7 years.
Managing this Scheme since
February 2018
Ultra Short Duration
Jul 31, 2006
CRISIL Ultra Short Term Debt Index
Regular Plan | |
Growth: | ₹ 2613.0287 |
Direct Plan | |
Growth: | ₹ 2738.2893 |
₹ 2,384 Cr
₹ 2,403 Cr
Regular Plan : | 1.00% |
Direct Plan : | 0.29% |
0.39 years
> 3 months
2,384
Modified Duration | 0.37 years |
Yield To Maturity | 5.19% |
Nil
Name of Instrument | Rating | % to Net Assets |
DEBT INSTRUMENTS | ||
BOND & NCD's | ||
Listed / awaiting listing on the stock exchanges | ||
✔ Power Finance Corporation Limited | CRISIL AAA | 6.95% |
REC Limited | CRISIL AAA | 3.57% |
Housing Development Finance Corporation Limited | CRISIL AAA | 3.35% |
Bajaj Finance Limited | CRISIL AAA | 2.17% |
Muthoot Finance Limited | CRISIL AA | 1.64% |
LIC Housing Finance Limited | CRISIL AAA | 1.11% |
National Housing Bank | CARE AAA | 0.43% |
Total | 19.22% | |
MONEY MARKET INSTRUMENTS | ||
Certificate of Deposit | ||
✔ ICICI Bank Limited | ICRA A1+ | 8.72% |
✔ Small Industries Development Bank of India | CARE A1+ | 8.11% |
✔ Bank of Baroda | IND A1+ | 6.15% |
✔ National Bank for Agriculture and Rural Development | IND A1+ | 5.34% |
✔ Axis Bank Limited | ICRA A1+ | 5.17% |
✔ Kotak Mahindra Bank Limited | CRISIL A1+ | 4.17% |
Export-Import Bank of India | CRISIL A1+ | 4.07% |
Axis Bank Limited | CRISIL A1+ | 2.08% |
Indian Bank | IND A1+ | 2.08% |
National Bank for Agriculture and Rural Development | CRISIL A1+ | 2.05% |
Small Industries Development Bank of India | CRISIL A1+ | 1.00% |
Total | 48.94% | |
Commercial Paper | ||
Listed / awaiting listing on the stock exchanges | ||
✔ Housing Development Finance Corporation Limited | CRISIL A1+ | 5.15% |
✔ Kotak Mahindra Prime Limited | CRISIL A1+ | 5.14% |
✔ Reliance Industries Limited | CRISIL A1+ | 4.12% |
Export-Import Bank of India | CRISIL A1+ | 4.10% |
Standard Chartered Investments and Loans (India) Limited | CRISIL A1+ | 3.92% |
Chennai Petroleum Corporation Limited | CRISIL A1+ | 3.34% |
Reliance Industries Limited | CARE A1+ | 2.27% |
Total | 28.04% | |
TREPS / Reverse Repo Investments / Corporate Debt Repo | 4.23% | |
Total | 4.23% | |
Cash & Cash Equivalent | ||
Net Receivables/Payables | -0.43% | |
Total | -0.43% | |
GRAND TOTAL | 100.00% |
✔ Top Ten Holdings
DSP Ultra Short Fund erstwhile known as DSP Money Manger Fund
Notes: 1. All corporate ratings are assigned by rating agencies like CRISIL, CARE, ICRA, IND.
2. Pursuant to SEBI circular SEBI/HO/IMD/DF4/CIR/P/2019/102 dated September 24, 2019 read with
circular no. SEBI/HO/IMD/DF4/CIR/P/2019/41 dated March 22, 2019. Below are the details of the
securities in case of which issuer has defaulted beyond its maturity date.
Security | ISIN |
value of the security
considered under net
receivables (i.e. value
recognized in NAV in
absolute terms and as
% to NAV) (Rs.in lakhs) |
total amount
(including
principal and
interest) that
is due to the
scheme on that
investment (Rs.in lakhs) | |
0% IL&FS Transportation Networks Limited Ncd Series A 23032019 | INE975G08140 | 0.00 | 0.00% | 6,627.81 |
Performance (CAGR Returns in %) | ||||
1 m | 3 m | 6 m | 1 yr | |
6.95 | 5.49 | 5.36 | 6.68 |
An Open ended income Scheme,
seeking to generate returns
commensurate with risk from a
portfolio constituted of money
market securities and/or debt
securities.
There is no assurance that the
investment objective of the
Scheme will be realized.
This Scheme is suitable for investors who are seeking*
• Income over a short-term investment horizon
• Investment in money market and debt securities
* Investors should consult their financial advisors if in doubt whether the product is suitable for them.